Evidence map›Paper›PMID 28707137›Full record

ArticleJournal of materials science. Materials in medicine2017

Surface modification of esophageal stent materials by a polyethylenimine layer aiming at anti-cancer function.

Kun Zhang, Yuxin Bai, Xiaofeng Wang, Qian Li, Fangxia Guan, Jingan Li

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Nanodrugs systems for therapy and diagnosis of esophageal cancer.Frontiers in bioengineering and biotechnology · 2023
    Review
  5. Futuristic Developments and Applications in Endoluminal Stenting.Gastroenterology research and practice · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kun ZhangSchool of Life Science, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, PR China.
Yuxin BaiSchool of Life Science, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, PR China.
Xiaofeng WangNational Center for International Research of Micro-nano Molding Technology & Key Laboratory for Micro Molding Technology of Henan Province, Zhengzhou, PR China.
Qian LiNational Center for International Research of Micro-nano Molding Technology & Key Laboratory for Micro Molding Technology of Henan Province, Zhengzhou, PR China.
Fangxia GuanSchool of Life Science, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, PR China.
Jingan LiNational Center for International Research of Micro-nano Molding Technology & Key Laboratory for Micro Molding Technology of Henan Province, Zhengzhou, PR China. lijingan@zzu.edu.cn.
Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal cancer is difficult to cure globally and possesses high mortality rate, and it is generally accepted that palliative care such as stent implantation is the main therapy method for esophageal cancer in later period. However, the restenosis caused by tumor cells and inflammatory cells seriously interferes the stent clinical application and limits its long-term services. To solve this problem, series of drug delivery stents were developed and proven rather effective in the early stage of implantation, but more serious restenosis occurred after the drug delivery was over, which endangered the patients' life. Therefore, endowing the esophageal stent continuous anti-cancer function become an ideal strategy for inhibiting the restenosis. In this contribution, the functional layer composed of polydopamine (PDA) and Poly-ethylenimine (PEI) with series of molecular weights (MW, 1.8 × 10

Indexed as

Drug-Eluting StentsEsophagusAntineoplastic AgentsApoptosisCell Line, TumorCell ProliferationCoated Materials, BiocompatibleDrug Delivery SystemsEsophageal NeoplasmsHumansIndolesMaterials TestingNecrosisPolyethyleneiminePolymersStainless SteelAntineoplastic AgentsCoated Materials, BiocompatibleIndolespolydopaminePolyethyleneiminePolymersStainless SteelWater

Identifiers

PMID28707137
OpenAlexW2735793545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.